As of 2026-03-23, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (90.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -150.7%.
The range of the Relative Valuation is (83.24) - (100.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.9x | 21.8x |
| Forward P/E multiples | 19.7x - 24.4x | 21.1x |
| Fair Price | (83.24) - (100.79) | (90.54) |
| Upside | -146.6% - -156.4% | -150.7% |
| Date | P/E |